	US 12,409,133 B2
	Therapeutic methods involving gastrointestinal implants
Scott Schorer, Duxbury, MA (US)
Assigned to Morphic Medical, Inc., Boston, MA (US)
Filed by GI Dynamics, Inc., Boston, MA (US)
Filed on Nov. 18, 2021, as Appl. No. 17/529,544.
Application 17/529,544 is a continuation of application No. 16/468,927, granted, now 11,179,325, issued on Nov. 23, 2021, previously published as PCT/US2017/065879, filed on Dec. 12, 2017.
Claims priority of provisional application 62/432,835, filed on Dec. 12, 2016.
Prior Publication US 2022/0160622 A1, May 26, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/00 (2006.01); A61K 35/741 (2015.01); A61K 35/76 (2015.01); A61K 38/26 (2006.01); A61F 5/00 (2006.01)

CPC A61K 9/0024 (2013.01) [A61K 35/741 (2013.01); A61K 35/76 (2013.01); A61K 38/26 (2013.01); A61F 5/0076 (2013.01)]

2 Claims

1. A method of treating a metabolic disorder in an individual undergoing treatment with a gastrointestinal implant comprising an anchor and a sleeve, the method comprising administering one or more metabolic agents to the individual in an amount and for a duration to treat the metabolic disorder.